Medication Adherence Research in COPD Patients

Completed

Conditions studied: COPD, Medication Adherence

In brief

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death, affects over 24 million people in the US and is the leading cause of disability with projected healthcare costs at almost $50 billion. The goal of this study is to identify novel and potentially powerful targets for behavioral interventions in COPD which has been understudied despite its tremendous detrimental impact on overall public health.

Key facts

Study ID

NCT03174704

Run by

Johns Hopkins University

People needed

314

Starts

2017-05-01

Expected to finish

2023-03-31

Last updated by the study team

2023-05-11

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 40 years of age or older
• Physician diagnosis of COPD
• Prescribed a long-term controller medication for COPD
• Moderate COPD on the basis of meeting one of the following criteria:
• Gold Stage II-IV disease with forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ≤70% and FEV1 (% predicted) <80% or
• One or more hospital admissions, two or more emergency department (ED) visits, or prescription of oral steroids for COPD exacerbation in the past 12 months or ever having used home oxygen
• Cognitive ability to provide informed consent

You may not qualify if…

• Non-English speaking

Where it is running

• Christiana Care Health System — Newark, Delaware, United States
• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.